Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Refractory Lupus Nephritis”

55 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 55 results

Not applicableLooking for participantsNCT06277427
What this trial is testing

Refractory ANCA Associated Vasculitis and Lupus Nephritis Treated With BCMA-targeting CAR-T Cells

Who this might be right for
Lupus NephritisANCA Associated Vasculitis
Lingli Dong 24
Testing effectiveness (Phase 2)Looking for participantsNCT07053800
What this trial is testing

Obe-cel in Severe, Refractory Systemic Lupus Erythematosus With Active Lupus Nephritis

Who this might be right for
Lupus Nephritis
Autolus Limited 35
Testing effectiveness (Phase 2)Looking for participantsNCT06897930
What this trial is testing

Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE

Who this might be right for
Lupus Erythematosus, Systemic
AstraZeneca 150
Testing effectiveness (Phase 2)WithdrawnNCT06153095
What this trial is testing

IMPT-514 in Active Refractory Lupus Nephritis (LN) and Systemic Lupus Erythematosus (SLE)

Who this might be right for
Systemic Lupus ErythematosusLupus Nephritis
Lyell Immunopharma, Inc.
Early research (Phase 1)Looking for participantsNCT06925542
What this trial is testing

A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease

Who this might be right for
SLE (Systemic Lupus)Lupus Erythematosus, SystemicLupus Nephritis+4 more
CRISPR Therapeutics 80
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07364396
What this trial is testing

Efficacy and Safety of CRC01 in Participants With Severe, Refractory Systemic Lupus Erythematosus

Who this might be right for
Lupus NephritisLupus Nephritis (LN)SLE+1 more
Curocell Inc. 39
Very early researchNot Yet RecruitingNCT07535138
What this trial is testing

Efficacy and Safety of CD19 CAR-γδ T Cells in the Treatment of Relapsed/Refractory Autoimmune Nephropathy

Who this might be right for
Membranous NephropathyLupus Nephritis (LN)IgA Nephropathy (IgAN)
Air Force Military Medical University, China 15
Very early researchLooking for participantsNCT06497387
What this trial is testing

Safety and Efficacy of PRG-1801 for Refractory Lupus Nephritis and IgG4-Related Disease

Who this might be right for
Lupus NephritisIgG4-related Disease
Tongji Hospital 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT06342960
What this trial is testing

KYSA-3: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Refractory Lupus Nephritis

Who this might be right for
Lupus NephritisLupus Nephritis - WHO Class IIILupus Nephritis - WHO Class IV
Kyverna Therapeutics 2
Testing effectiveness (Phase 2)Active Not RecruitingNCT05938725
What this trial is testing

KYSA-1: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Refractory Lupus Nephritis

Who this might be right for
Lupus NephritisLupus Nephritis - World Health Organization (WHO) Class IIILupus Nephritis - WHO Class IV
Kyverna Therapeutics 6
Early research (Phase 1)Active Not RecruitingNCT06064929
What this trial is testing

Learn More About the Safety and Effects of Felzartamab in Adults With Lupus Nephritis Aged 18 to 75 Years Old

Who this might be right for
Lupus Nephritis
HI-Bio, A Biogen Company 14
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06935474
What this trial is testing

C-CAR168 CAR T Cell Therapy for Refractory Autoimmune Disease

Who this might be right for
Lupus Nephritis (LN)
AbelZeta Inc. 24
Large-scale testing (Phase 3)Study completedNCT01328834
What this trial is testing

Efficacy and Safety of Tacrolimus Sustained-release Capsules in Induction Treatment in Refractory Lupus Nephritis

Who this might be right for
Nephritis, Lupus
Sun Yat-sen University 20
Early research (Phase 1)Looking for participantsNCT07104721
What this trial is testing

A Clinical Study of YTS109 Cell for R/R Autoimmune Diseases

Who this might be right for
Systemic Lupus Erythematosus (SLE)Lupus Nephritis (LN)Systemic Sclerosis (SSc)+3 more
China Immunotech (Beijing) Biotechnology Co., Ltd. 18
Post-approval studies (Phase 4)Study completedNCT01203709
What this trial is testing

Low-dose Combination of Mycophenolate Mofetil (MMF) and Tacrolimus (Tac) for Refractory Lupus Nephritis

Who this might be right for
Lupus Nephritis
Tuen Mun Hospital 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07570862
What this trial is testing

A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis

Who this might be right for
Lupus NephritisSystemic Lupus ErythematosusSLE - Systemic Lupus Erythematosus+2 more
Fate Therapeutics 53
Not applicableLooking for participantsNCT07403188
What this trial is testing

A Long-Term Follow-Up Study for Participants Previously Treated With KYV-101

Who this might be right for
Refractory Lupus NephritisMyasthaenia GravisStiff Person Syndrome+4 more
Kyverna Therapeutics 70
Early research (Phase 1)Active Not RecruitingNCT06265220
What this trial is testing

AB-101 in Combination With B-Cell Depleting mAb in Patients Who Failed Treatment for Class III or IV Lupus Nephritis or Other Forms of Refractory Systemic Lupus Erythematosus

Who this might be right for
Lupus Nephritis - WHO Class IIILupus Nephritis - WHO Class IVRefractory Systemic Lupus Erythematosus+1 more
Artiva Biotherapeutics, Inc. 51
Early research (Phase 1)Looking for participantsNCT06708845
What this trial is testing

US Zamto-cel Autoimmune Diseases

Who this might be right for
Lupus NephritisSystemic Lupus ErythematosusSystemic Sclerosis (SSc)+1 more
Miltenyi Biomedicine GmbH 48
Early research (Phase 1)Looking for participantsNCT07115745
What this trial is testing

Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases

Who this might be right for
Refractory Autoimmune Diseases
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company 125
Load More Results